Symmetric herpes zoster: atypical herpes zoster presentation in renal transplant patient
DOI:
https://doi.org/10.66344/jpad.v26i2.61Keywords:
Herpes zoster, atypical presentationAbstract
Herpes zoster (HZ) is not uncommon viral disease which develops in 20% of immunocompetent individuals and 50% of immunocompromised patients. This disease has significant morbidity and can be fatal. Thus early identification and management of this viral illness is critical to diminish the serious sequels. HZ can have unusual presentations in immunocompromised patients as in our patient who developed asymptomatic, symmetric erosive eruption in multiple dermatomes. Unusual presentation of herpes zoster can interfere with early recognition of this disease and subsequently with initial management leading to severe complications. This report highlights the typical and atypical manifestations, complications as well as the management of HZ.
References
1. Gould D. Varicella zoster virus: chickenpox and shingles. Nurs Stand. 2014;28(33):52-8.
2. Bostikova V, Salavec M, Smetana J, Chlibek R, Kosina P, Prasil P, Plisek S et al. An unusual case of multi-recurrent herpes zoster (Hz): a case report. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155(4):397-401.
3. Wilson DD. Herpes zoster: A rash demanding careful evaluation. Nurse Pract. 2014;39(5):30-6.
4. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant. 2004;4(1):108-15.
5. Gnann JW Jr. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002;186(1):91-8.
6. Reuler JB, Chang MK. Herpes zoster: epidemiology, clinical features, and management. South Med J. 1984;77:1149-56.
7. Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013;81:928-30.
8. Fashner J, Bell AL. Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Physician. 2011;83:1432-7.
9. Gershon AA, Gershon MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev. 2013;26:728-43.
10. Sanjay S, Huang P, Lavanya R. Herpes zoster ophthalmicus. Curr Treat Options Neurol. 2011;13:79-91.
11. Roesel M, Heiligenhaus A, Messmer EM. Clinical presentation of zoster ophthalmicus. Klin Monbl Augenheilkd. 2010;227(5):370-4.
12. Wagner G, Klinge H, Sachse MM. Ramsay-Hunt syndrome. J Dtsch Dermatol Ges. 2012;10 (4):238-44.
13. Bader MS. Herpes zoster: diagnostic, therapeutic, and preventive approaches. Postgrad Med. 2013;125 (5):78-91.
14. Johnson RW. Herpes zoster and post-herpetic neuralgia. Expert Rev Vaccines. 2010;9(3):21-6.
15. O'Connor KM, Paauw DS. Herpes zoster. Med Clin North Am. 2013;97 (4):503-22,
16. Gan EY, Tian EA, Tey HL. Management of herpes zoster and post-herpetic neuralgia. Am J Clin Dermatol. 2013;14(2):77-85.
17. Ruocco V, Ruocco E, Brunetti G, Russo T, Gambardella A, Wolf R. Wolf’s post-herpetic isotopic response: Infections, tumors, and immune disorders arising on the site of healed herpetic infection. Clin Dermatol. 2014;32 (5):561-8.
18. Gopal MG, Shannoma, Kumar B C S, Manjunath NC. A comparative study to evaluate the efficacy and safety of acyclovir and famciclovir in the management of herpes zoster. J Clin Diagn Res. 2013;7:2904-7.
19. Wallis KA, Hood LJ, Rao K. Herpes zoster: when do patients present and who gets antiviral treatment? J Prim Health Care. 2014;6(2):108-13.
20. Kim SR, Khan F, Ramirez-Fort MK, Downing C, Tyring SK. Varicella zoster: an update on current treatment options and future perspectives. Expert Opin Pharmacother. 2014;15(1):61-71.
21. Hales CM, Harpaz R, Ortega-Sanchez I, Bialek SR .Update on recommendations for use of herpes zoster vaccine. MMWR Morb Mortal Wkly Rep. 2014;63 (33):729-31.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Mariam Al Zaabi, Mohamed Alsuwaiji, Nuha Nasser
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
